Shenzhen Hepalink Pharmaceutical Co Ltd Capital Reinvestment Ratio
Shenzhen Hepalink Pharmaceutical Co Ltd capital reinvestment ratio. Shenzhen Hepalink Pharmaceutical Co Ltd (002399) has a Capital Reinvestment Ratio of 0.03x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥399.43 Million) in capital expenditures (CN¥13.60 Million). Check total reinvestment intensity of Shenzhen Hepalink Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Shenzhen Hepalink Pharmaceutical Co Ltd (2006–2025)
Capital reinvestment ratio of Shenzhen Hepalink Pharmaceutical Co Ltd from 2006 to 2025. This chart tracks Shenzhen Hepalink Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 16 annual periods. Also explore 002399 net asset momentum to track the company's year-over-year net asset growth rate.
Shenzhen Hepalink Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2006–2025)
Shenzhen Hepalink Pharmaceutical Co Ltd capital reinvestment ratio by year from 2006 to 2025. For the full cash flow conversion analysis, see cash efficiency ratio of Shenzhen Hepalink Pharmaceutical Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | CN¥1.71 Billion | CN¥121.10 Million | ▼ -23.5% |
| 2024 | 0.09x | CN¥2.19 Billion | CN¥202.77 Million | ▼ -91.7% |
| 2023 | 1.12x | CN¥398.22 Million | CN¥444.88 Million | ▼ -80.4% |
| 2020 | 5.70x | CN¥37.28 Million | CN¥212.49 Million | ▲ +611.5% |
| 2018 | 0.80x | CN¥667.87 Million | CN¥535.01 Million | ▼ -22.9% |
| 2016 | 1.04x | CN¥346.07 Million | CN¥359.54 Million | ▲ +449.9% |
| 2015 | 0.19x | CN¥893.71 Million | CN¥168.85 Million | ▲ +2.9% |
| 2014 | 0.18x | CN¥912.80 Million | CN¥167.62 Million | ▼ -73.7% |
| 2013 | 0.70x | CN¥420.97 Million | CN¥293.98 Million | ▲ +39.3% |
| 2012 | 0.50x | CN¥473.89 Million | CN¥237.55 Million | ▲ +425.0% |
| 2011 | 0.10x | CN¥1.41 Billion | CN¥134.16 Million | ▼ -5.7% |
| 2010 | 0.10x | CN¥354.86 Million | CN¥35.93 Million | ▼ -34.4% |
| 2009 | 0.15x | CN¥355.81 Million | CN¥54.91 Million | ▼ -42.7% |
| 2008 | 0.27x | CN¥40.13 Million | CN¥10.81 Million | ▼ -68.8% |
| 2007 | 0.86x | CN¥13.85 Million | CN¥11.95 Million | ▲ +477.7% |
| 2006 | 0.15x | CN¥71.66 Million | CN¥10.71 Million | — |